1Bloom BR,Murray CJL.Commentary on a reemengent killer,Science, 1992, 257 : 1055.
2Neville K,Brombeng A,Bromberg R,et al. The third epidemicmultidrug-resistant tuberclosis, Chest, 1994,105:45.
3Cohn ML, Kovitz C, Oda U, et al. Studies on isoniazid and tubercle bacilli Ⅱ. The growth requirements,catalase activities, and pathogenic properties of isoniazid-resistant mutate. Am Rev Tuberc,1954, 70:641.
4Middlebrook G. Isoniazid-resistance and catalase activity of tubercle bacilli. Am Rev Tuherc, 1954, 69 :471.
5Wolinsky E, Smith MM, Steenken W, et al. Isoniazid susceptibility, catalase activity, and guinea pig virulence of recently isolated cultures of tubercle bacilli. Am Rev Tuberc, 1956, 73:768.
6Hedgeoack LW, Faueher I0. Relation of pyrogallol-peroxidase activity to isoniazid resistance in mycobacterium tuberculosis. Am Rev Tuberc. 1957,75 : 670.
7Rastogi N. Mode of action of antituberculous drugs and mecharnisms of drug resistance in Mycobacterium tuberculosis.Res Microbiol,1993.144:133.
8Frank R. Rapid identification of a point mutation of the mycobacterium tuberculosis catalase-peroxidase (KatG) gene associated with isoniazid resistance. J Infect Dis, 1995,171:240.
9Youatt J, Tham SH. An enzyme system of mycobacterium tuberculosis that reacts specifically with isoniazid. Am Rev Respir Dis,1969,100 : 25.
10Winder FM.Mode of action of antimycobacteria agents and associated aspects of the molecular biology of mycobacteria.The biology of mycobacteria,1982,1 :354.
